Add to ORKG2. Dufour A, Schneider F, Metzeler KH, et al: Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome. J Clin Oncol 28:570-577, 2010 3. Fröhling S, Schlenk RF, Stolze I, et al: CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: Prognostic relevance and analysis of cooperating mutations. J Clin Oncol 22:624-633, 200
interpreted data, and wrote the paper; P.B. performed cytogenetics; L.A. and C.E. collected clinical...
Full list of author information is available at the end of the articleBackground Acute myeloid leuka...
In this issue ofBlood, Ho and colleagues report the independent predictive value of single genemutat...
CCAAT/enhancer-binding protein alpha (CEBPA) mutations are a favorable prognostic factor in adult ac...
Key Words. Acute myelogenous leukemia • Cytogenetic abnormalities • Bone marrow transplantation Hema...
Full list of author information is available at the end of the articleBackground Acute myeloid leuke...
Purpose To determine the clinical relevance of mutations in the CCAAT/enhancer binding protein α (CE...
We evaluated concurrent gene mutations, clinical outcome, and gene expression signatures of CCAAT/en...
Acute myeloid leukemia with biallelic mutation of CEBPA (CEBPA-dm AML) is a distinct good prognosis ...
Purpose: The transcription factor CCAAT/enhancer binding protein , encoded by the CEBPA, is crucial ...
Publisher Copyright: © 2021, The Author(s).Acute myeloid leukemia (AML) is a hematological malignanc...
Mixed phenotype acute leukemia (MPAL) encompasses a heterogeneous group of rare leukemias in which a...
Acute myelocytic leukemia (AML) has an incidence of around 10,000 new cases annually in the United S...
PURPOSE: The transcription factor CCAAT/enhancer binding protein-alpha (CEBPA) is crucial for normal...
publisher[Abstract] Acute myeloid leukemia (AML) is a clonal disorder that is caused by acquired som...
interpreted data, and wrote the paper; P.B. performed cytogenetics; L.A. and C.E. collected clinical...
Full list of author information is available at the end of the articleBackground Acute myeloid leuka...
In this issue ofBlood, Ho and colleagues report the independent predictive value of single genemutat...
CCAAT/enhancer-binding protein alpha (CEBPA) mutations are a favorable prognostic factor in adult ac...
Key Words. Acute myelogenous leukemia • Cytogenetic abnormalities • Bone marrow transplantation Hema...
Full list of author information is available at the end of the articleBackground Acute myeloid leuke...
Purpose To determine the clinical relevance of mutations in the CCAAT/enhancer binding protein α (CE...
We evaluated concurrent gene mutations, clinical outcome, and gene expression signatures of CCAAT/en...
Acute myeloid leukemia with biallelic mutation of CEBPA (CEBPA-dm AML) is a distinct good prognosis ...
Purpose: The transcription factor CCAAT/enhancer binding protein , encoded by the CEBPA, is crucial ...
Publisher Copyright: © 2021, The Author(s).Acute myeloid leukemia (AML) is a hematological malignanc...
Mixed phenotype acute leukemia (MPAL) encompasses a heterogeneous group of rare leukemias in which a...
Acute myelocytic leukemia (AML) has an incidence of around 10,000 new cases annually in the United S...
PURPOSE: The transcription factor CCAAT/enhancer binding protein-alpha (CEBPA) is crucial for normal...
publisher[Abstract] Acute myeloid leukemia (AML) is a clonal disorder that is caused by acquired som...
interpreted data, and wrote the paper; P.B. performed cytogenetics; L.A. and C.E. collected clinical...
Full list of author information is available at the end of the articleBackground Acute myeloid leuka...
In this issue ofBlood, Ho and colleagues report the independent predictive value of single genemutat...